Stereotactic ablative radiation therapy for brain metastases with volumetric modulated arc therapy and flattening filter free delivery: feasibility and early clinical results

Stereotactic ablative radiation therapy for brain metastases with volumetric modulated arc... Radiol med (2017) 122:676–682 DOI 10.1007/s11547-017-0768-0 NEURORADIOLOGY Stereotactic ablative radiation therapy for brain metastases with volumetric modulated arc therapy and flattening filter free delivery: feasibility and early clinical results 1 1 1 1 Alba Fiorentino · Niccolò Giaj‑Levra · Umberto Tebano · Rosario Mazzola · 1 1 2 1 Francesco Ricchetti · Sergio Fersino · Gioacchino Di Paola · Dario Aiello · 1 1 Ruggero Ruggieri · Filippo Alongi Received: 4 November 2016 / Accepted: 12 April 2017 / Published online: 26 April 2017 © Italian Society of Medical Radiology 2017 Abstract follow-up time of 12 months (range 1–27 months), the Aim For selected patients with brain metastases (BMs), median overall survival was 14 months and the 6-month the role of stereotactic radiosurgery (SRS) or fractionated overall survival was 77%. Finally, the median intracranial stereotactic radiotherapy (SFRT) is well recognized. The disease control was 11 months. Acute and late toxicities recent introduction of flattening filter free (FFF) delivery were acceptable without severe events (no adverse events during linac-based SRS or SFRT allows shorter beam-on- ≥G2 were recorded). time, improving patients’ comfort and facility workflow. Conclusions These preliminary results highlighted the Nevertheless, limited experiences evaluated the impact of feasibility and http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png La radiologia medica Springer Journals

Stereotactic ablative radiation therapy for brain metastases with volumetric modulated arc therapy and flattening filter free delivery: feasibility and early clinical results

Loading next page...
 
/lp/springer_journal/stereotactic-ablative-radiation-therapy-for-brain-metastases-with-qBz90VvxMO
Publisher
Springer Milan
Copyright
Copyright © 2017 by Italian Society of Medical Radiology
Subject
Medicine & Public Health; Imaging / Radiology; Diagnostic Radiology; Interventional Radiology; Neuroradiology; Ultrasound
ISSN
0033-8362
eISSN
1826-6983
D.O.I.
10.1007/s11547-017-0768-0
Publisher site
See Article on Publisher Site

Abstract

Radiol med (2017) 122:676–682 DOI 10.1007/s11547-017-0768-0 NEURORADIOLOGY Stereotactic ablative radiation therapy for brain metastases with volumetric modulated arc therapy and flattening filter free delivery: feasibility and early clinical results 1 1 1 1 Alba Fiorentino · Niccolò Giaj‑Levra · Umberto Tebano · Rosario Mazzola · 1 1 2 1 Francesco Ricchetti · Sergio Fersino · Gioacchino Di Paola · Dario Aiello · 1 1 Ruggero Ruggieri · Filippo Alongi Received: 4 November 2016 / Accepted: 12 April 2017 / Published online: 26 April 2017 © Italian Society of Medical Radiology 2017 Abstract follow-up time of 12 months (range 1–27 months), the Aim For selected patients with brain metastases (BMs), median overall survival was 14 months and the 6-month the role of stereotactic radiosurgery (SRS) or fractionated overall survival was 77%. Finally, the median intracranial stereotactic radiotherapy (SFRT) is well recognized. The disease control was 11 months. Acute and late toxicities recent introduction of flattening filter free (FFF) delivery were acceptable without severe events (no adverse events during linac-based SRS or SFRT allows shorter beam-on- ≥G2 were recorded). time, improving patients’ comfort and facility workflow. Conclusions These preliminary results highlighted the Nevertheless, limited experiences evaluated the impact of feasibility and

Journal

La radiologia medicaSpringer Journals

Published: Apr 26, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off